How should we value medicines and their benefits to society?
How can Sweden better assess the value of medicines, not only for patients but also for society and the economy? In a new podcast episode, Karl Wennberg, Professor and Director of the Center for Resilient Health at the Stockholm School of Economics, discusses how healthcare investments can create broader societal benefits.
In the latest episode of Bristol Myers Squibb's podcast Hand in Hand Conversations, Karl Wennberg joins Joakim Ramsberg, Head of Science and Society at the Swedish Brain Foundation, and Jessica Lundström, Nordic Head of Government Affairs at Bristol Myers Squibb.
The discussion explores whether current models for evaluating medicines capture their full value, including their impact on patients, healthcare systems, societal resilience, and the economy.
The conversation raises broader questions about how society should prioritize healthcare investments and what a more comprehensive approach to valuing medical treatments could mean for future healthcare policy.
Listen to the podcast (in Swedish): Hand in Hand Conversations - The value of medicines
